文献速递生殖医学

男性不育与心脏代谢疾病风险:一项基于人群的队列研究

Male infertility and risk of cardiometabolic conditions: a population-based cohort study.
PubMed 文献 · Hum Reprod · 2026-01-01

该基于人群的队列研究纳入2009年1月至2016年9月在澳大利亚新南威尔士州伴侣受孕的445 909名男性,随访5年,发现诊断为男性不育的男性在控制已测量混杂因素后,高血压、心脏病和糖尿病的风险适度增加,但脑血管疾病无显著差异,且部分重要混杂因素测量不足。

要点

  • 与生育力正常的父亲相比,不育男性高血压、全心脏病、非缺血性心脏病、缺血性心脏病和糖尿病的风险适度增加。
  • 不育男性脑血管疾病发病率与生育力正常男性相比无显著差异。
  • 不育可能是心脏代谢风险轻度升高的早期指标,但部分重要混杂因素测量不足。

核心结论

  • 控制已测量混杂因素后,诊断为男性不育的父亲与生育力正常父亲相比,心脏病、糖尿病和高血压风险适度增加,但一些重要混杂因素仍测量不足。

研究设计与样本

  • 基于人群的队列研究,纳入2009年1月至2016年9月在澳大利亚新南威尔士州伴侣受孕的445 909名男性,从索引日期起随访5年至2021年9月。
  • 排除2009年前诊断不育、子女受孕时年龄不满14岁、索引日期前6.5年内诊断心脏代谢疾病的男性。
  • 使用有向无环图确定潜在混杂路径,采用逆概率处理加权和g计算控制已测量混杂因素,使用稳健泊松回归估计调整边际风险比和调整边际风险差。

主要发现

  • 高血压事件17 433例,5年粗发病率生育力正常男性41.09/1000人、不育男性70.03/1000人,aRR=1.20(95%CI 1.11-1.31,P<0.001),aRD=1.1%(95%CI 0.6%-1.6%,P<0.001)。
  • 全心脏病事件15 549例,5年粗发病率生育力正常男性36.44/1000人、不育男性59.88/1000人,aRR=1.20(95%CI 1.09-1.31,P<0.001),aRD=0.9%(95%CI 0.4%-1.4%,P<0.001)。
  • 非缺血性心脏病事件5183例,aRR=1.26(95%CI 1.08-1.48,P=0.004),aRD=0.4%(95%CI 0.1%-0.7%,P=0.009);缺血性心脏病事件12 628例,aRR=1.13(95%CI 1.02-1.25,P=0.020),aRD=0.4%(95%CI 0.1%-0.7%,P=0.028)。
  • 糖尿病事件7064例,5年粗发病率生育力正常男性16.05/1000人、不育男性27.59/1000人,aRR=1.28(95%CI 1.12-1.46,P<0.001),aRD=0.6%(95%CI 0.2%-0.9%,P=0.001)。
  • 脑血管疾病事件512例,aRR=1.0(95%CI 0.56-1.80,P=0.996),aRD=0.0%(95%CI -0.1%至0.1%,P=0.996),无显著差异。

临床怎么用

  • 作者认为,男性不育可能作为心脏代谢风险轻度升高的早期指标,特别是高血压、糖尿病和各种形式的心脏病。
  • 作者从公共卫生角度提出,生育治疗可能是对诊断为不育的男性进行早期发现和干预以帮助预防心脏代谢疾病发生的机会。

局限性

  • 队列仅包括生育了孩子的男性,因此未寻求生育、无法生育或难以获得生殖保健的男性可能未被纳入,可能产生选择效应,使估计值偏向无效。
  • 由于数据限制,无法充分控制若干混杂因素,包括吸烟、饮食、心肺适能和酒精摄入等重要生活方式因素,可能使估计值偏离无效。
  • 未测量和测量不足的混杂因素组合可能削弱观察到的估计值。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: Is male infertility independently associated with an increased risk of incident hypertension, ischemic and non-ischemic heart disease, diabetes, and/or cerebrovascular disease? SUMMARY ANSWER: Fathers diagnosed with male infertility have a modestly increased risk of heart disease, diabetes, and hypertension compared with fertile fathers, after controlling for measured confounders; however, some important confounders remain inadequately measured. WHAT IS KNOWN ALREADY: Cohort studies suggest that infertile men have an increased risk of incident cardiometabolic diseases, including diabetes, hypertension, heart disease, and cerebrovascular disease, although findings are mixed. The reasons for this association are unclear, but cardiometabolic conditions and male infertility share a wide range of shared etiological factors including age, chronic conditions such as obesity and obstructive sleep apnea, cancers and their treatments, environmental exposures such as pollution and pesticides, lifestyle factors such as smoking and cardiorespiratory fitness, autoimmune conditions such as lupus and Hashimoto's thyroiditis, as well as congenital conditions such as cystic fibrosis and muscular dystrophy. STUDY DESIGN, SIZE, DURATION: Our population-based cohort study included 445 909 men whose partner conceived a child between January 2009 and September 2016 in New South Wales (NSW), Australia. We excluded men with a diagnosis of infertility prior to 2009, men who were under the age of 14 at the time of the child's conception, and men diagnosed with cardiometabolic conditions in the 6.5 years prior to their index date. The index date was the later of the date of the child's conception or the date of the vasectomy for fertile men or the date of diagnosis of infertility for infertile men, i.e. the time when the exposure status was determined. From the index date, we followed participants for 5 years up until the latest available date of September 2021. PARTICIPANTS/MATERIALS, SETTINGS, METHODS: The study was conducted in NSW, Australia. We determined infertility status by a diagnosis of male infertility in the Australian and New Zealand Assisted Reproduction Database, hospital records, or a record of fertility-related procedures. We assessed the following outcomes: incident hypertension, ischemic and non-ischemic heart disease, all heart disease, diabetes, and cerebrovascular disease. We calculated age-standardized prevalence rates at baseline. We mapped potential confounding pathways using directed acyclic graphs and controlled for measured confounders using inverse probability of treatment weighting and g-computation. We estimated adjusted marginal risk ratios (aRR) and adjusted marginal risk differences (aRD) using robust Poisson regression. MAIN RESULTS AND THE ROLE OF CHANCE: The number of events and 5-year crude incidence rate for the outcomes were: hypertension (events: 17 433, fertile: 41.09 per 1000 population, infertile: 70.03 per 1000 population), all heart disease (events: 15 549, fertile: 36.44 per 1000 population, infertile: 59.88 per 1000 population), ischemic heart disease (events: 12 628 fertile: 29.24 per 1000 population, infertile: 47.1 per 1000 population), non-ischemic heart disease (events: 5183, fertile: 11.69 per 1000 population, infertile: 20.24 per 1000 population), cerebrovascular disease (events: 512, fertile: 1.14 per 1000 population, infertile: 1.78 per 1000 population) and diabetes (events: 7064, fertile: 16.05 per 1000 population, infertile: 27.59 per 1000 population). Compared with fertile men, men diagnosed with infertility demonstrated increased risk of incident disease for: hypertension aRR = 1.20 (95% CI 1.11-1.31, P < 0.001), aRD = 1.1% (95% CI: 0.6%-1.6%, P < 0.001); all heart disease aRR = 1.20 (95% CI 1.09-1.31, P < 0.001), aRD =0.9% (95% CI: 0.4%-1.4%, P < 0.001); non-ischemic heart disease aRR = 1.26 (95% CI 1.08-1.48, P = 0.004), aRD = 0.4% (95% CI: 0.1%-0.7%, P = 0.009); ischemic heart disease aRR = 1.13 (95% CI 1.02-1.25, P = 0.020), aRD = 0.4% (95% CI: 0.1%-0.7%, P = 0.028); and diabetes aRR = 1.28 (95% CI 1.12-1.46, P < 0.001), aRD 0.6% (0.2%-0.9%, P = 0.001). There was no significant difference in the incidence of cerebrovascular disease, aRR = 1.0 (95% CI 0.56-1.80, P = 0.996), aRD = 0.0% (95% CI: -0.1% to 0.1%, P = 0.996). These results remained consistent in sensitivity analyses, including an expanded exposure definition of infertility, a 10-year follow-up period, changing the outcomes of people who died in follow-up, and using an alternative index date. LIMITATIONS, REASONS FOR CAUTION: The cohort includes men who fathered a child, so men who did not seek to, or were unable to, have a child, and men with poor access to the reproductive healthcare may not be included. This may generate selection effects, biasing the estimates toward the null. We were unable to adequately control for several confounders, including important lifestyle factors like smoking, diet, cardiorespiratory fitness, and alcohol intake, due to data limitations, which may bias estimates away from the null. It appears plausible that a combination of unmeasured and inadequately measured confounders may attenuate the observed estimates. WIDER IMPLICATIONS OF THE FINDINGS: These findings suggest that male infertility may serve as an early indicator for a slightly heightened cardiometabolic risk, specifically relating to hypertension, diabetes, and various forms of heart disease. Our study is the largest on this topic, with extensive control for confounders. Our findings align with published research, indicating that men diagnosed with infertility have a slightly higher risk of incident diabetes, hypertension, and heart disease. From a public health perspective, fertility treatment may be an opportunity for earlier detection and intervention to help prevent the onset of cardiometabolic conditions in men diagnosed with infertility, particularly given that men generally have low rates of contact with the health system. STUDY FUNDING/COMPETING INTEREST(S): The PhD candidacy of J.M. is supported by Medical Research Future Fund (MRFF) Emerging Priorities and Consumer Driven Research initiative: EPCD000007, 2020. M.K.O'B. and G.M.C. declare receiving payment to their institution by the same MRFF grant. G.M.C. reports receiving funding from an Australian MRFF grant paid to UNSW to support this work, and J.M. reports receiving PhD funding from the same MRFF grant. C.V. declares an unpaid role on Human Reproduction's Editorial Board, and paid employment at the University of New South Wales (UNSW) until January 2023. The National Perinatal Epidemiology and Statistics Unit (NPESU), which belongs to UNSW, is custodian of the Australian and New Zealand Assisted Reproduction Database (ANZARD). Data from ANZARD were used in this study. G.M.C. also declares paid employment from UNSW. The remaining authors have nothing to declare. TRIAL REGISTRATION NUMBER: N/A.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Marozzi J, Hanly M, Venetis C, et al. Male infertility and risk of cardiometabolic conditions: a population-based cohort study. Hum Reprod. 2026. PMID: 41285026. doi:10.1093/humrep/deaf218

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。